Cargando…
Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper
Biologic therapy with anti–tumor necrosis factor (TNF)-α antibody medications has become part of the standard of care for medical therapy for patients with inflammatory bowel disease and may help to avoid surgery in some. However, many of these patients will still require surgical intervention in th...
Autores principales: | Holubar, Stefan D., Holder-Murray, Jennifer, Flasar, Mark, Lazarev, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623843/ https://www.ncbi.nlm.nih.gov/pubmed/26422516 http://dx.doi.org/10.1097/MIB.0000000000000603 |
Ejemplares similares
-
An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel Disease
por: Tkacz, Joseph, et al.
Publicado: (2015) -
Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study
por: Randell, Rachel L, et al.
Publicado: (2016) -
Physician Suicide Prevention and the Ethics and Role of a Healing Community: an American College of Physicians Policy Paper
por: DeCamp, Matthew, et al.
Publicado: (2021) -
Palliative care in primary care: European Forum for Primary Care position paper
por: Rotar Pavlič, Danica, et al.
Publicado: (2019) -
Position paper: ability to drive in cerebrovascular diseases
por: Marx, Peter, et al.
Publicado: (2019)